Bids Are Invited For Acquisition Of Cannabidiol 50Mg/Ml And 200Mg/Ml Oral Solution, For Patients Undergoing High-Cost Processes, From Ordinance No. 139-2015 Dgp And Other Medications. The Indication Of The Specific Brand Prati Donaduzzi Arises From A Technical Justification Presented By The Doctor, Considering A Previously Observed Satisfactory Therapeutic Response, The Patients Clinical Stability And Risk Of Decompensation With Eventual Replacement By A Different Product, Even If Similar.